Living meta-analysis and evidence synthesis of therapies for COVID-19

click on circles to display study description...

ELACOI (Standard of care), 2020 NCT04252885

umifenovir (arbidol) (n=16) vs. standard of care (n=7)

randomized controlled trial   some concerns about risk of bias

Studied treatment

arbidol
arbidol (100mg) (oral, 200mg TID for 7-14 days)

Control treatment

standard care

3 arms : lopinavir/ritonavir; arbidol and standard care

Patients

COVID 19 all comers

Method

open-label

China, single center

Remark